Compare IBCP & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBCP | CNC |
|---|---|---|
| Founded | 1864 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 675.6M | 18.7B |
| IPO Year | N/A | 2001 |
| Metric | IBCP | CNC |
|---|---|---|
| Price | $33.53 | $39.89 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 17 |
| Target Price | $36.00 | ★ $40.06 |
| AVG Volume (30 Days) | 159.1K | ★ 6.2M |
| Earning Date | 01-22-2026 | 02-03-2026 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | ★ 10.56 | N/A |
| EPS | ★ 3.25 | N/A |
| Revenue | $222,890,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | N/A | $32.54 |
| Revenue Next Year | $5.16 | $0.19 |
| P/E Ratio | $10.34 | ★ N/A |
| Revenue Growth | 7.05 | ★ 14.57 |
| 52 Week Low | $26.75 | $25.08 |
| 52 Week High | $37.13 | $66.81 |
| Indicator | IBCP | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 57.92 |
| Support Level | $34.80 | $38.58 |
| Resistance Level | $35.67 | $40.15 |
| Average True Range (ATR) | 0.76 | 1.26 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 12.30 | 58.80 |
Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.